Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 203

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients

Open access
Leite, M.I., Coutinho, E., Lana-Peixoto, M., Apostolos, S., Waters, P., Sato, D., Melamud, L., Marta, M., Graham, A., Spillane, J., Villa, A.M., Callegaro, D., Santos, E., da Silva, A. Martins, Jarius, S., Howard, R., Nakashima, I., Giovannoni, G., Buckley, C., Hilton-Jones, D., Vincent, A., Palace, J. · 2012 · Neurology

Abstract

Objective: To describe 16 patients with a coincidence of 2 rare diseases: aquaporin-4 antibody (AQP4-Ab)–mediated neuromyelitis optica spectrum disorder (AQP4-NMOSD) and acetylcholine receptor antibody (AChR-Ab)–mediated myasthenia gravis (AChR-MG). Methods: The clinical details and antibody results of 16 patients with AChR-MG and AQP4-NMOSD were analyzed retrospectively. Results: All had early-onset AChR-MG, the majority with mild generalized disease, and a high proportion achieved remission. Fifteen were female; 11 were Caucasian. In 14/16, the MG preceded NMOSD (median interval: 16 years) and 11 of these had had a thymectomy although 1 only after NMOSD onset. In 4/5 patients tested, AQP4-Abs were detectable between 4 and 16 years prior to disease onset, including 2 patients with detectable AQP4-Abs prior to thymectomy. AChR-Abs decreased and the AQP4-Ab levels increased over time in concordance with the relevant disease. AChR-Abs were detectable at NMOSD onset in the one sample available from 1 of the 2 patients with NMOSD before MG. Conclusions: Although both conditions are rare, the association of MG and NMOSD occurs much more frequently than by chance and the MG appears to follow a benign course. AChR-Abs or AQP4-Abs may be present years before onset of the relevant disease and the antibody titers against AQP4 and AChR tend to change in opposite directions. Although most cases had MG prior to NMOSD onset, and had undergone thymectomy, NMOSD can occur first and in patients who have not had their thymus removed. Ab= : antibodies; AChR-Ab= : acetylcholine receptor antibody; AChR-MG= : acetylcholine receptor antibody–mediated myasthenia gravis; AQP4-Ab= : aquaporin-4 antibody; AQP4-NMOSD= : aquaporin-4 antibody–mediated neuromyelitis optica spectrum disorder; IgG= : immunoglobulin G; IS= : immunosuppressive; LETM= : longitudinally extensive transverse myelitis; MG= : myasthenia gravis; NMO= : neuromyelitis optica; NMOSD= : neuromyelitis optica spectrum disorder; OCB= : oligoclonal bands; ON= : optic neuritis; SLE= : systemic lupus erythematosus; VGKC= : voltage-gated potassium channel

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e31825644ff

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 203

Metadata

Authors
Leite, M. I., Coutinho, E., Lana-Peixoto, M., Apostolos, S., Waters, P., Sato, D., Melamud, L., Marta, M., Graham, A., Spillane, J., Villa, A. M., Callegaro, D., Santos, E., da Silva, A. M., Jarius, S., Howard, R., Nakashima, I., Giovannoni, G., Buckley, C., Hilton-Jones, D., Vincent, A., & Palace, J.
Venue
Neurology
Published
2012-05-15
Volume
78
Issue
20
Pages
1601-1607
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2018496511
Cited by
203
References
2
FWCI
11.78
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients. https://app.cochat.ai/papers/10.1212/wnl.0b013e31825644ff
The paper
Leite, M. I., Coutinho, E., Lana-Peixoto, M., Apostolos, S., Waters, P., Sato, D., Melamud, L., Marta, M., Graham, A., Spillane, J., Villa, A. M., Callegaro, D., Santos, E., da Silva, A. M., Jarius, S., Howard, R., Nakashima, I., Giovannoni, G., Buckley, C., . . . Palace, J. (2012). Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients. Neurology. https://doi.org/10.1212/wnl.0b013e31825644ff

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.